Tag: HCV
Self-Reported and Objective Compliance for HCV Treatment Reflect Different Cure Rates
The HERO (Hepatitis C Real Options) study found that self-reported compliance with direct-acting antiviral (DAA) therapy for HCV treatment in persons who inject...
A Significant Step Towards Public Health
For decades, many Americans with hepatitis C have struggled to get into the continuum of care. And unfortunately, some have died waiting for...
Global Access to Hepatitis C Treatments
A study published in The Lancet discusses access to reimbursement for direct-acting antivirals (DAAs) is globally uneven, with low and middle-income countries (LMICs)...
Achieving SVR Reduces Risk of Cardiovascular Events in Patients with HCV
This article originally appeared on our sister site, HCPLive. Hepatitis C virus (HCV) eradication with direct-acting antiviral (DAA) therapy may decrease the risk...
Overestimation of Hepatitis C Prevalence Hinders Cost-Effectiveness of Universal Screening
Aiden McCormickCredit: Irish ExaminerThis article originally appeared on our sister site, HCPLive. Findings from a pair of studies examining the community prevalence of...
Top Infectious Disease Stories: Week of February 5
This week, a study advocates enhancing hospital cleaning protocols to halt healthcare-associated infections; integrating HCV testing and antivirals in prisons to cut transmission...